Time & Location
25 Nov 2023, 15:15 – 15:45
Main Hall, Cutlers' Hall
About the event
Mathew Embry, the Founder of MS Hope and an advocate of nutrition, optimal vitamin D, exercise and HSCT (Hematopoietic Stem Cell Transplantation), is supporting AIMS by speaking to further their efforts in creating exposure for this treatment. He believes that raising awareness about HSCT is crucial so that patients are informed about this powerful method to halt the progression of Multiple Sclerosis (MS) compared to conventional medications.
In addition to creating exposure, Mathew supports AIMS in bringing together medical experts in the field of MS to engage in discussions about HSCT. By being parts of these conversations, he aims to promote a better understanding of the treatment's potential and its role in managing MS effectively.
Moreover, Mathew finds it significant to consider how HSCT plays a role with the Epstein Barr virus, as there may be relevant connections or implications for MS patients.
Through his involvement with AIMS and his media outreach efforts, Mathew Embry endeavours to empower patients with knowledge about HSCT, its potential benefits, and its role in the context of MS and related factors like the Epstein Barr virus.